Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood-brain barrier and exhibits potent activity against glioblastoma
新型化合物 SYHA1813 的临床前和早期临床研究，该化合物可有效穿过血脑屏障，并表现出对胶质母细胞瘤的强效活性
期刊:Acta Pharmaceutica Sinica B
影响因子:14.7
doi:10.1016/j.apsb.2023.09.009
Yingqiang Liu, Zhengsheng Zhan, Zhuang Kang, Mengyuan Li, Yongcong Lv, Shenglan Li, Linjiang Tong, Fang Feng, Yan Li, Mengge Zhang, Yaping Xue, Yi Chen, Tao Zhang, Peiran Song, Yi Su, Yanyan Shen, Yiming Sun, Xinying Yang, Yi Chen, Shanyan Yao, Hanyu Yang, Caixia Wang, Meiyu Geng, Wenbin Li, Wenhu D
